Colorectal Neoplasms Clinical Trial
Official title:
Evaluation of the Effectiveness of a Collaborative Strategy to Increase the Screening of Colorectal Cancer in the Public Healthcare Sector in Argentina
Verified date | April 2019 |
Source | Institute for Clinical Effectiveness and Health Policy |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Introduction: Early detection of certain types of cancer significantly increases the
likelihood of successful treatment and reduces mortality from these causes. However, the use
of screening and the early detection of selected tumors such as colorectal cancer (CRC) are
lower than those expected in our country. The objective of this project is to evaluate the
effectiveness of a multicomponent strategy that improves the screening and early detection of
CRC in the population at risk of Primary Health Care Clinics (PCCs) of the public health
system.
Population: people leaving in the catchment area of 10 selected primary care clinics from the
public health system in the province of Mendoza, Argentina.
Design and methods: a Randomized clinical study by clusters. 10 PCCs will be included: 5 will
be randomly assigned to receive an intervention to increase the CRC screening rates
(improvement cycles) and 5 to the control arm (usual care). 150 participants will be included
in each PCCs, in total, 1500 participants.
Intervention: An innovative vision is proposed, which combines a participatory and dynamic
methodology based on improvement cycles. This approach includes the implementation of
participatory learning sessions for health providers, involving the effectors of the design
of the intervention. In the intervention branch at least 3 workshops (sessions) will be held
with the members of the care system, in order to identify opportunities for improvement
oriented to the design and application of an innovative intervention based on best practices.
Each one of the sessions will constitute an analysis of the improvement cycle, following the
following steps: 1) Selection of participants of the initial workshop; 2) Development of work
model based on bibliographic review and initial qualitative phase; 3) Initial workshop with
effectors for training in continuous improvement, objectives, interventions and data
collection; 4) Learning workshops to discuss results, applicability of interventions and
modifications to the work plan; 5) Closing session to evaluate preliminary results and
discuss continuity of interventions beyond the project.
Outcomes: 1) Percentage of the population at risk that completes the screening; 2) Percentage
of the population classified as at habitual risk or increased by risk factors.
Status | Active, not recruiting |
Enrollment | 1520 |
Est. completion date | March 15, 2020 |
Est. primary completion date | March 15, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 50 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Subjects who have public health coverage - Age between 50 and 75 years old - Residence in the catchment area of the PCCs - With an indication to perform screening for CRC with FOBT - People who consent to participate Exclusion Criteria: - People who are bedridden. - People who plan to move in the next 3 months. |
Country | Name | City | State |
---|---|---|---|
Argentina | Ministry of Health | Mendoza |
Lead Sponsor | Collaborator |
---|---|
Institute for Clinical Effectiveness and Health Policy | Inter-American Development Bank |
Argentina,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Effective Screening | Proportion of participants who with known result of the FOBT within 90 days from recruitment. The investigators will review National Information System Registry to count the number of participants in each arm with a known result for their FOBT. The investigators will calculate the proportion of participants with known result (Effective Screening) in each arm of the study. | 3 months | |
Secondary | Proportion of participants with inadequate FOBT | The investigators will register the number of cases in each arm where the result of the FOBT is unknown because the test was inadequate, that is, the test could not be read. | 3 months | |
Secondary | Proportion of positive FOBT referred for colonoscopy | The investigators will calculate the proportion of participants with a positive result in the FOBT that were referred to receive colonoscopy. | 3 months | |
Secondary | Implementation outcomes according to the RE-AIM framework | Implementation outcomes are: Reach, Effective implementation, adoption, implementation fidelity and maintenance | 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04552093 -
Hepatic Arterial Infusion Pump Chemotherapy Combined With Systemic Chemotherapy (PUMP-IT)
|
Phase 2/Phase 3 | |
Completed |
NCT04192565 -
A Prospective Investigation of the ColubrisMX ELS System
|
N/A | |
Completed |
NCT05178745 -
A Prospective Observational Cohort Study Evaluating Resection Rate in Patients With Metastatic Colorectal Cancer Treated With Aflibercept in Combination With FOLFIRI - Observatoire résection
|
||
Recruiting |
NCT03561350 -
Detect Microsatellite Instability Status in Blood Sample of Advanced Colorectal Cancer Patients by Next-Generation Sequencing
|
||
Recruiting |
NCT06128798 -
Effect of Preoperative Immunonutrition Versus Standard Oral Nutrition in Patient Undergoing Colorectal Surgery.
|
N/A | |
Recruiting |
NCT03602677 -
Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage
|
N/A | |
Completed |
NCT03631407 -
Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Microsatellite Stable (MSS) Colorectal Cancer (CRC) (MK-7690-046)
|
Phase 2 | |
Withdrawn |
NCT04192929 -
Chromoendoscopy or Narrow Band Imaging (NBI) for Improving Adenoma Detection in Colonoscopy
|
N/A | |
Recruiting |
NCT03042091 -
Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery
|
Early Phase 1 | |
Terminated |
NCT02842580 -
De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal Cancer
|
Phase 2 | |
Completed |
NCT02889679 -
Underwater Resection of Non-pedunculated Colorectal Lesions
|
N/A | |
Completed |
NCT02564835 -
Effects of Yoga on Cognitive and Immune Function in Colorectal Cancer
|
N/A | |
Completed |
NCT02503696 -
Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)
|
N/A | |
Completed |
NCT02149108 -
Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1)
|
Phase 3 | |
Completed |
NCT02599103 -
The Effects of Various Cooking Oils on Health Related Biomarkers in Healthy Subjects
|
N/A | |
Completed |
NCT01669109 -
Hatha Yoga for Patients With Colorectal Cancer
|
N/A | |
Completed |
NCT01719926 -
Phase I Platinum Based Chemotherapy Plus Indomethacin
|
Phase 1 | |
Recruiting |
NCT01428752 -
Study of Prevalence of Colorectal Adenoma in 30- to 49-year-old Subjects With a Family History of Colorectal Cancer
|
N/A | |
Completed |
NCT01978717 -
General Anesthesia Combined With Epidural Anesthesia Mitigates the Surgical Stress-related Immunosuppression in Patients With Colorectal Cancer
|
N/A | |
Completed |
NCT01877018 -
Colorectal Cancer Screening in Primary Care
|
N/A |